Introduction
============

The epidemiology of AGWs in most of SSA is largely unknown since few studies have been conducted. Studies from high income countries show that the clinical burden has been increasing over the years since approximately 0.5-1.0% of adults below 50 years have AGWs \[[@B1]-[@B3]\].

Caused mainly by low-risk HPV type 6 and 11, AGWs affect both men and women \[[@B1]\]. They are highly infectious with about 65% of individuals with an infected partner developing lesions within 3 weeks \[[@B4]\]. The median time between infection and development of lesions is about 11--12 months among men \[[@B5],[@B6]\] and about 5--6 months among women \[[@B7]\]. Rarely, AGWs have been associated with malignant Bushke-Lowenstein malignant tumors \[[@B8]\]. Their occurrence is strongly linked to HIV and weakly associated with cigarette smoking \[[@B1],[@B4],[@B5]\]. At present, the impact of highly active anti-retroviral therapy (HAART) remains unclear \[[@B5],[@B6]\].

Except for Rwanda \[[@B9]\], most countries in SSA are yet to introduce or scale up HPV vaccination in national immunization programs. While reduction in disease burden due to HPV 16/18 may not be evident for decades, vaccination with the quadrivalent HPV vaccine should result in immediate measurable reduction in the incidence rate of AGWs. Preliminary results from the Australian national HPV vaccination program shows a significant decline in the number of cases of AGWs among the young vaccinated women and some herd-immunity effect in young unvaccinated heterosexual men \[[@B10]\]. This review was undertaken to assess the prevalence, incidence and risk factors for AGWs before the introduction of HPV vaccination programs in order to provide a basis for future program evaluation in SSA.

Methods
=======

Identification and eligibility of relevant studies
--------------------------------------------------

PubMed/MEDLINE, Africa Index Medicus and HINARI websites were searched for peer reviewed English language published medical literature from January 1, 1984 up to June 30, 2012. The following Medical Subject Heading (MESH) and search terms were used alone or in combination "Sub Saharan Africa" AND ("anogenital warts" OR "venereal warts" OR "condylomata acuminata" OR "condylomata") AND "risk factors". Relevant additional references cited in published papers were also evaluated for inclusion. For inclusion, articles had to meet the following criteria (1) original studies with clear estimation of prevalence and/or incidence rates among men and/or women (2) detailed description of study population (3) clinical or self-reported diagnosis of AGWs (4) HPV genotyping of histologically confirmed AGWs. Studies focusing exclusively on case reports and commentaries were excluded.

Data extraction
---------------

From each article, the following information was extracted: first author, publication journal name and year of publication, country of study population, study sample type (population- or clinic- based), study design, mean or median age with range/inter quartile range, whenever available, sample size, prevalence and/or incidence rate overall and by HIV status, whenever available, risk factors and the overall prevalence of HIV, whenever available. For studies that included populations from different countries, data was extracted separately for each country.

Statistical analysis
--------------------

Data across different studies were synthesized using descriptive statistics for different subgroups of females and males by geographical areas. A meta- analysis of relative risk was conducted for studies that had data reported by HIV status and results presented in a forest plot. In total, 40 studies (39 hospital - and 1 population-based) are included in this review.

Results
=======

The prevalence and incidence rates of AGWs in diverse female and male hospital-based study populations in East, Central and South, and West African regions is summarized in Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}. Overall, there is inter- and intra-region variations in rates depending on the underlying prevalence rate of HIV-1 infection, study population and age group studied. While both young and adult populations were studied, there seems to be no trend or pattern of prevalence rates by age.

###### 

Studies reporting prevalence of AGWs in women

  **Author,**                          **Country**                    **Study design**                            **Study population**                                     **Sample size**                                                                                           **Mean or Median age**                          **Prevalence of AGWs**^**2**^**n (%)**                                  **Prevalence**                        **Comments**
  ------------------------------------ ------------------------------ ------------------------------------------- -------------------------------------------------------- --------------------------------------------------------------------------------------------------------- ----------------------------------------------- ----------------------------------------------------------------------- ------------------------------------- ---------------------------------------------------------------------------------------------------------------------------
  ***East Africa***                                                                                                                                                                                                                                                                                                                                                                                                                                
  Kreiss et al., 1992 \[[@B11]\]       Kenya                          ^§^Cross-sectional                          Sex workers                                              196                                                                                                       30.2 (HIV-1+) 31.5 (HIV-1-)                     18/196 (9.2) Overall 15/145 (10.0) HIV-1+ 3/51 (6.0) HIV-1                                                     
  Fonck, et al., 2000 \[[@B12]\]       Kenya                          \"EntryTbl_st^§^Cross-sectional             Women attending STD^3^ clinic                            520                                                                                                       26 ± 6.8 (14--49)                               31/520 (6 .0) 5/520 (1.0)^a^                                            29.0                                  Prevalence of AGWs 5% (Non pregnant women) 9% (Pregnant women) 6% (One sexual partner)
  Mayaud et al., 2001 \[[@B13]\]       Tanzania                       ^§^Cross-sectional                          Pregnant women                                           660                                                                                                       23.4 ± 5.1 (15--44)                             20/660 (3.0)                                                            15.0                                   
  Riedner et al., 2003 \[[@B14]\]      Tanzania                       ^§^Open cohort                              Female bar workers                                       600                                                                                                       25.4                                            39/600 (6.5) Overall 39/408 (9.6) HIV + 0/192 (0.0) HIV -               68.0                                   
  Namkinga et al., 2005 \[[@B15]\]     Tanzania                       ^§^Cross-sectional                          Women presenting with complaints of genital infections   464                                                                                                                                                       18/464 (3.9)                                                            22.0                                   
  Amone-P\'Olak, 2005 \[[@B16]\]       Uganda                         ^‡^Cross-sectional                          Formally abducted teenage girls in Northern Uganda       123                                                                                                       16.2 ± 2.2 (12--18)                             67/123 (54.5)^a^                                                                                               
  Mbizvo et al., 2005 \[[@B17]\]       Tanzania                       ^§^Cross --sectional                        Women seeking primary health care services               382                                                                                                       26.7 ± 6.0                                      8/382 (2.1)                                                             11.5                                   
  Msuya et al., 2006 \[[@B18]\]        Tanzania                       ^§^Cross-sectional                          Women seeking reproductive health care services          382                                                                                                       24.6 (14--43)                                   7/382 (2.0)                                                             6.9                                    
  Riedner et al., 2006 \[[@B19]\]      Tanzania                       ^§^Serial cross-sectional                   Female bar workers                                       600                                                                                                       25.5 (16--39)                                   5.2-10.7                                                                67.0                                   
  Aboud et al., 2008 \[[@B20]\]        TanzaniaMalawi and Zambia      ^§^Cross-sectional                          HIV-1 positive pregnant women                            2292                                                                                                      (15--49)                                        195/2292 (8.5)                                                                                                Prevalence of AGWs Blantyre -- 42/474 (8.9) Lilongwe -- 61/748 (8.2) Dar es Salaam -- 31/428 (7.2) Lusaka -- 61/642 (9.5)
  Banura et al., 2008a \[[@B21]\]      Uganda                         Baseline of a prospective cohort study      Young women attending a clinic for teenagers             1275                                                                                                      20 (12--24)                                     97/1275 (7.6)                                                           8.6                                    
  Banura et al., 2008b \[[@B22]\]      Uganda                         ^§^Baseline of a prospective cohort study   Pregnant women Attending ANC^5^                          987                                                                                                       19 (14--24)                                     61/987 (6.2)                                                            7.3                                    
  Urassa et al., 2008 \[[@B23]\]       Tanzania                       ^§^Cross-sectional                          Youth attending an STI^4^ clinic                         214                                                                                                       20.2 (Females) (13--24) 21.5 (Males) (11--24)   7/214 (3.3)                                                             15.3                                  HIV −1 prevalence in Males -- 7.5%
  Grijsen et al., 2008 \[[@B24]\]      Kenya                          ^§^Baseline of a prospective cohort study   Women at risk for HIV-infection                          361                                                                                                       27 (23--32)                                     8/361 (2.4)                                                             32.0                                   
  Msuya et al., 2009 \[[@B18]\]        Tanzania                       ^§^Cross-sectional                          Pregnant women                                           2655                                                                                                      24.6 (14--43)                                   11/2555 (0.4) Overall 2/184 (1.1) HIV + 9/2470 (0.4) HIV -              6.9                                    
  Mapingure, et al., 2000 \[[@B25]\]   Tanzania                       ^§^Cross-sectional                          Pregnant women                                           2654                                                                                                      24.6                                            34/2654 (1.3) 48/2654 (1.8)^b^                                          6.9                                    
  ***Central and South Africa***                                                                                                                                                                                                                                                                                                                                                                                                                    
  Latif et al., 1984 \[[@B26]\]        Zimbabwe                       ^§^Cross-sectional                          Pregnant women attending STD clinic                      175                                                                                                       22.3                                            23/175 (13.7)                                                                                                  
  Mason et al., 1990 \[[@B27]\]        Zimbabwe                       ^§^Cross-sectional                          Women attending STD clinic                               100                                                                                                       (15--45)                                        14/100 (14.0) 1/59 (1.7)^a^                                                                                    
  Kristensen 1990 \[[@B28]\]           Malawi                         ^§^Cross sectional                          Adult women with symptoms of STIs                        16,218                                                                                                    26.8 ± 7.5                                      32/16,218 (0.2)                                                         62.4                                   
  Nzila et al., 1991 \[[@B29]\]        Democratic Republic of Congo   ^§^Cross-sectional                          Female sex workers                                       1233                                                                                                                                                      30/1233 (2.4) Overall 21/431 (5.0) HIV + 8/802 (1.0) HIV-               35.0                                   
  Le Bacq et al., 1993 \[[@B30]\]      Zimbabwe                       ^§^Cross-sectional                          New STD clinic attendees                                 146                                                                                                                                                       19/146 (13.0)                                                           69.0                                   
  Maher et al., 1995 \[[@B31]\]        Malawi                         ^§^Cross-sectional                          Female patients in general medical care                  61                                                                                                        31 (16--65)                                     6/61 (9.8)                                                                                                     
  Taha et al., 1998 \[[@B32]\]         Malawi                         ^§^Serial cross-sectional surveys           Pregnant women                                           1990 -- 6603 *HIV + 1502 HIV- 5101* 1993 -- 2161 *HIV + 694 HIV- 1457* 1995 -- 808 *HIV + 808 HIV- 701*                                                   1990 1993 1995 Overall 4.8 3.1 2.5 HIV + 8.3 6.3 2.7 HIV- 2.2 1.7 1.0   23.0 (1990) 30.1 (1993) 32.6 (1995)    
  Klaskala et al., 2005 \[[@B33]\]     Zambia                         ^§^Cross-sectional                          Pregnant women                                           3160                                                                                                      25 ± 5.3 (14--43)                               203/3160 (6.2)                                                                                                 
  Mbizvo et al., 2005 \[[@B17]\]       Zimbabwe                       ^§^Cross --sectional                        Women recruited from primary health care centers         386                                                                                                       26.5 ± 6.8                                      13/386 (3.4)                                                            29.3                                   
  Kurewa et al., 2010 \[[@B34]\]       Zimbabwe                       ^§^Cross-sectional                          Pregnant women                                           691                                                                                                       24.2 ± 5.1                                      48/691 (7.0) 50 /691 (7.3)^a^                                           25.6                                   
  Mapingure et al., 2010 \[[@B26]\]    Zimbabwe                       ^§^Cross-sectional                          Pregnant women                                           691                                                                                                       24.2 ± 5.1                                      50/691 (7.3) 33/691 (4.8)^b^                                            25.6                                   
  Menendez et al., 2010 \[[@B35]\]     Mozambique                     ^§^Cross- sectional                         Women attending ANC and FP^6^ clinics and community      262                                                                                                       (14--61)                                        13/262 (5.0)                                                            12.0                                  Prevalence of HIV-1 21.0% among FP clinic attendees
  ***West Africa***                                                                                                                                                                                                                                                                                                                                                                                                                                
  Oni et al., 1994 \[[@B36]\]          Nigeria                        ^§^Cross-sectional                          STD clinic attendees                                     116                                                                                                                                                       12/116 (10.5)                                                                                                  
  Ghys et al., 1995 \[[@B37]\]         Ivory Cost                     ^§^Cross sectional                          Female sexual workers                                    1209                                                                                                                                                      105/1209 (8.7) Overall 79/567 (14.0) HIV + 26/642 (4.0) HIV -           80.0                                   
  Meda et al., 1997 \[[@B38]\]         Burkina Faso                   ^§^Cross -- sectional                       Women attending ANC                                      645                                                                                                       25.3 ± 2.9 (15--41)                             19/645 (2.9)                                                                                                   
  Okesola et al., 2000 \[[@B39]\]      Nigeria                        ^§^Cross-sectional                          Patients attending an STD clinic                         861                                                                                                       (17--74)                                        68/861 (8.0)                                                                                                   
  Bakare et al., 2002 \[[@B40]\]       Nigeria                        ^§^Cross-sectional                          CSWs^7^ and women without symptoms of STIs                                                                                                                                                                         6.5 36.4^c^                                                             34.3                                   
  Domfeh et al., 2008 \[[@B41]\]       Ghana                          ^§^Cross-sectional                          Women attending gynecological clinic                     75                                                                                                        33.3 ± 9.2 (19--57)                             4/75 (5.3)^a^                                                                                                  
  Sagay et al., 2009 \[[@B42]\]        Nigeria                        ^§^Cross-sectional                          Female sex workers                                       374                                                                                                       27.8 ± 6.7 (16--63)                             17/374 (4.5)                                                                                                  Prevalence of AGWs 5/81 (6.1%) Lemon users 12/293 (4.1%) Non Lemon users
  Jombo et al., 2009 \[[@B43]\]        Nigeria                        ^§^Cross- sectional                         Patients with genital ulcer disease                      699                                                                                                                                                       369/699 (52.8) Overall 285/506 (56.4) HIV + 84/193 (43.6) HIV --                                              Prevalence *Males*: 13/329 (2.6%) *Females*: 8/177 (1.6%)
  Low et al., 2011 \[[@B44]\]          Burkina Faso                   ^§^Baseline of Prospective cohort           CSWs and other women with high-risk sexual behaviors     765                                                                                                       28 (15--54)                                     27/765 (3.5) Overall 19/273 (7.0) HIV −1 + 8/492 (1.6) HIV -            34.9 HIV-1 0.7 HIV-1 &2               No prevalent AGWs among women on HAART

^a^ self-reported prevalence; ^b^ self-reported prevalence for the last 12 months; ^c^ self-reported prevalence among commercial sexual workers; ^1^Inter quartile range; ^2^Anogenital warts; ^3^Sexually transmitted disease; ^4^Sexually transmitted infection; ^5^Antenatal care; ^6^Family planning; ^7^Commercial sexual workers; ^§^ hospital-based study; ^‡^ Teenagers in an institution.

###### 

Studies reporting AGWs in men

  **Author, year**                    **Country**    **Study design**                             **Study population**                                 **Sample**   **Mean or Median age**   **Prevalence of AGWs**^**2**^**(%)**                                   **Prevalence of HIV-1%**   **Comments**
  ----------------------------------- -------------- -------------------------------------------- ---------------------------------------------------- ------------ ------------------------ ---------------------------------------------------------------------- -------------------------- ----------------------------------------------
  **East Africa**                                                                                                                                                                                                                                                                              
  Grijsen et al., 2008 \[[@B24]\]     Kenya          ^§^Baseline of a prospective cohort study    Men at high-risk for HIV infection                   536          27 (24--33)              9/500 (1.8)                                                            21.0                        
  Smith et al., 2010 \[[@B45]\]       Kenya          ^§^Baseline of RCT^3^ on male circumcision   HIV negative sexually active men                     2168         20 (19--28)              12/2168 (0.6) Overall 10/1089 (0.9) HIV + 2/1079 ( 0.2) HIV-                                       
  Tobian et al., 2012 \[[@B46]\]      Uganda         ^†^Cross-sectional                           Heterosexual men                                     1399         15-49                    23/1399 (1.6)^a^ Overall 16/421 (3.8)^a^ HIV + 7/978 (0.7)^a^ HIV --                               
  **Central and South Africa**                                                                                                                                                                                                                                                                 
  Le Bacq et al., 1993 \[[@B31]\]     Zimbabwe       ^§^Cross-sectional                           New STD clinic attendees                             319                                   39/319 (12.2)                                                          61.0                        
  Maher et al. 1995 \[[@B32]\]        Malawi         ^§^Cross-sectional                           In-patient male patients in general medical care     62           39 (20--90)              3/62 (4.8)                                                                                         
  Machekano et al., 2000 \[[@B47]\]   Zimbabwe       ^§^Baseline of prospective cohort study      Male factory workers who reported symptoms of STDs   374                                   22/374 (6.0)                                                           20                          
  Müller et al., 2010 \[[@B48]\]      South Africa   ^§^Cross-sectional                           Heterosexual men attending sexual health services    214          29.8 ± 7.5               108/214 (50.5)                                                         49.5                        
  **West Africa**                                                                                                                                                                                                                                                                              
  Okesola et al., 2000 \[[@B40]\]     Nigeria        ^§^Cross-sectional                           STD^2^ clinic attendees                              1,373        17-74                    4.1                                                                                                
  Wade et al., 2005 \[[@B49]\]        Senegal        ^§^Cross sectional                           Men who have sex with men                            463          18-52                    13/463 (2.8)                                                           18.1                       21.5% Overall 0.5% HIV-2 2 2.9% HIV-1 & HIV-

^a^ Self-reported prevalence.

^1^Inter Quartile Range.

^2^Commercial sexual workers.

^3^Randomized Controlled Trial.

^§^hospital-based study.

^†^Population-based study.

###### 

Studies reporting incidence rates of AGWs in men and women

  **Author, year**                   **Country**           **Study design**                        **Study population**                 **Sample**            **Mean or**                    **Incidence rate/100**^**2**^           **HIV −1**  **Comments**
  --------------------------------- -------------- --------------------------------- ------------------------------------------------- ------------ ------------------------------- ----------------------------------------------- ------------ -----------------------------------------------------
  **East Africa**                                                                                                                                                                                                                                
  Lavreys et al., 1999 \[[@B50]\]       Kenya             Prospective cohort               HIV negative truck drivers in Mombasa           746       26^a^ (17--58) 29^b^ (16--62)   1.4 overall 1.7 Uncircumcised 1.3 Circumcised               Annual incidence of HIV-1 -- 3.0%
  **West Africa**                                                                                                                                                                                                                                
  Ozumba et al., 1991 \[[@B51]\]       Nigeria      Retrospective cohort (1976--85)           Female STD^1^ clinic attendees                45                21 ( 5--36)                       2.7 (range:1.6 -- 3.6)                           AGWs incidence highest among teenagers and students
  Low et al., 2011 \[[@B44]\]        Burkina Faso         Prospective cohort          Female sex workers and other women at high risk      765                28 (15--54)                              1.1 HIV -                        34.9     HIV- 1 & HIV-2 prevalence 0.7%

^a^ uncircumcised men.

^b^ circumcised men.

^1^Sexually Transmitted Diseases.

^2^Anogenital warts.

Prevalence rates among women by geographical region
---------------------------------------------------

The prevalence rates among women in East, Central and South, and West African regions are summarized in Tables [1](#T1){ref-type="table"}. The prevalence rates of clinical AGWs among sex workers and women with STDs or at high risk for other STIs range from 3.3% - 10.7% in East, 2.4% - 14.0% in Central and South, and 3.5% - 10.5% in West African regions. Among pregnant women, the prevalence rates range from 0.4% - 3.0% in East, 0.2% - 7.3% in Central and South and 2.9% (single study) in West African regions.

Prevalence rates of AGWs among men by geographical region
---------------------------------------------------------

Eight (8) studies (3 East Africa, 2 Central and South Africa, 3 West Africa) reported prevalence rates of AGWs in men (Table [2](#T2){ref-type="table"}). The prevalence rate among STD clinic attendees, men who have sex with men, and men with symptoms of STDs in Central and South and West African region range from 4.8% - 12.2% and 2.8% - 4.1%, respectively. The rates among men in the East African region range from 0.6 -1.8 percent.

Prevalence rates by HIV status
------------------------------

The prevalence rates of AGWs were significantly higher among HIV+ than HIV- women in all regions with an overall summary relative risk of 1.62 (95% CI: 1.43--1.82) (Figure [1](#F1){ref-type="fig"}). Similarly among men, clinical and self -reported prevalence rates were higher among HIV+ than HIV- men (Table [2](#T2){ref-type="table"}).

![Relative Risk of AGWs among women with known HIV sero status.](1750-9378-8-27-1){#F1}

Incidence rates of AGWs among men and women
-------------------------------------------

Only 3 studies (2 among females and 1 among males) reported incidence rates of AGWs (Table [3](#T3){ref-type="table"}). The incidence rates range from 1.1 -- 2.7 per 100 person-years among women and 1.4 per 100 person years among men. The incidence rate was higher among uncircumcised (1.7 per 100 person-years) than circumcised men (1.3 per 100 person-years) \[[@B44]\].

HPV 6 and/or 11 in AGWs
-----------------------

Only 3 studies reported the prevalence of HPV 6 and/or 11 in biopsy specimens or swabs taken from AGWs. HPV 11 was detected in 100% vulval-vaginal wart specimens obtained from 9 prepubescent South African girls \[[@B52]\]. HPV 6 and/or 11 was detected in 96.3% of 108 genital swabs taken from heterosexual men with AGWs attending sexual health clinics in South Africa \[[@B48]\]. Among 74 specimens taken from penile warts of HIV+ men in South Africa, HPV 6 was detected in 42.5%, HPV 11 in 32.9% and HPV 6/11 in 68.5% \[[@B53]\].

Risk factors for AGWs
---------------------

Only 2 studies (one among women and another among men) reported on risk factors for AGWs. Among women, the risk of prevalent AGWs was 5 times higher among HIV-1+ than HIV-1- women and 3 times higher among women who smoked cigarettes than those who did not. Among HIV-1+ women with low CD4+ count (≤ 200 cells/μL), the risk of incident AGWs was elevated 20 fold, and 6fold for women with CD4+ count \>200 cells/μL. Other risk factors for incident AGWs in women include detection of HPV 6, concurrent bacterial vaginoses, genital ulceration, presence of abnormal cervical cytology and the detection of cervical HPV 52 \[[@B44]\]. Lack of circumcision and HIV infection were risk factors for AGWs in men \[[@B45]\].

Discussion
==========

To the best of our knowledge this is the first systematic review of the epidemiology of AGWs in SSA. The literature suggests that AGWs are prevalent among both men and women populations seeking care in their respective health care systems. The fewer studies among men is not surprising given that women generally have more frequent contact with the health care system than men. Although there is no marked difference between regions, absence of a standardized protocol for diagnosis might have contributed to the observed variations across studies within the same region. Overall, the prevalence rates were higher than those reported from retrospective administrative databases or medical chart reviews in high income countries possibly because of underlying HIV infection in several studies \[[@B54]\].

Consistent with published studies, the risk for AGWs was higher for HIV+ than HIV- men and women \[[@B55]\]. HIV+ women had almost 2 fold risk for HPV infection than HIV-women. While some AGWs may have been a result of new infections, recrudescence of existing HPV infection has been reported among sexually inactive HIV+ women \[[@B56]\]. Impaired CD4+ T-lymphocyte response and other forms of immune dysfunction may be responsible for altering the natural history of HPV infection among HIV infected individuals \[[@B57]\]. The use of highly active anti-retroviral therapy has been shown to reduce the risk of opportunistic malignancies such as Kaposi sarcoma among HIV+ individuals \[[@B58]\], however, their impact on AGWs remains unclear \[[@B55],[@B57],[@B59]\]*.* On the other hand consistent use of male condoms appears to reduce the risk by 60-70% \[[@B60]\].

Consistent with other studies, HPV 6 and 11 alone or in combination were detected in the few studies that examined HPV genotypes in AGWs specimens albeit small sample sizes. However, the contribution of HPV 11 to the development of AGWs remains unclear \[[@B4],[@B7]\]. The concurrent detection of HPV 52 with HPV 6 was not surprising as co-infection with high risk HPV types has been reported in 20-50% of AGWs \[[@B61],[@B62]\].

In the absence of a clinical test to establish sub clinical HPV 6 and 11 infections, identification of risk factors for acquisition of AGWs independent of other STDs is complex. Consistent with other studies, low CD4+ cell count (≤ 200 cells/μL) and abnormal cervical and anal dysplasias are risk factors for AGWs in HIV+ women and men, respectively \[[@B63],[@B64]\]. Other risk factors for AGWs in women identified in this review included co-infection with HPV 52, and concurrent bacteria vaginoses \[[@B65]\]. In men, anal HPV infection and related dysplasias \[[@B39]\] and lack of circumcision \[[@B45]\] were additional risk factors.

Although AGWs are not life threatening, they cause significant psychological distress and are refractory to conventional therapies, hence the need for prevention \[[@B4],[@B66]\]. The quadrivalent HPV vaccine, correct and consistent condom use and limiting the number of sexual partners are some of the prevention options available to reduce the risk of contracting AGWs.

It is important to note that there are limitations to this study. This review focused only on peer reviewed English language articles published from a few SSA countries, which limits generalization of the findings. Secondly, most studies were conducted in hospital-based study populations, which would favor higher rates than in the general population. Thirdly, the rates should be interpreted with caution because of the differences in study populations and age group studied. While some studies included all adults \[[@B31],[@B39]\], others focused on narrow age ranges of specific populations like young people and pregnant women \[[@B23],[@B25]\] that could have resulted in the observed high rates. Nevertheless, the review provides vital baseline data against which the impact of HPV vaccination could be evaluated in future.

Conclusions
===========

AGWs are common among selected populations particularly HIV+ men and women. However, there is need for population-based studies on AGWs that will guide policies on effective prevention, treatment and control services.
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